| 摘要 |
Compounds, tautomers and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula Ia, as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed. |
| 申请人 |
Pfizer Inc. |
发明人 |
Anderson, David Randolph;Bunnage, Mark Edward;Curran, Kevin Joseph;Dehnhardt, Christoph Martin;Gavrin, Lori Krim;Goldberg, Joel Adam;Han, Seungil;Hepworth, David;Huang, Horng-Chih;Lee, Arthur;Lee, Katherine Lin;Lovering, Frank Eldridge;Lowe, Michael Dennis;Mathias, John Paul;Papaioannou, Nikolaos;Patny, Akshay;Pierce, Betsy Susan;Saiah, Eddine;Strohbach, Joseph Walter;Trzupek, John David;Vargas, Richard;Wang, Xiaolun;Wright, Stephen Wayne;Zapf, Christoph Wolfgang |
